| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.
|
Blood
|
2010
|
2.26
|
|
2
|
Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).
|
Haematologica
|
2007
|
2.03
|
|
3
|
Aggressive non-Hodgkin's lymphoma: concomitant evaluation of interleukin-2, soluble interleukin-2 receptor, interleukin-4, interleukin-6, interleukin-10 and correlation with outcome.
|
Leuk Lymphoma
|
2006
|
1.65
|
|
4
|
Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection.
|
J Pharm Biomed Anal
|
2009
|
1.63
|
|
5
|
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.
|
Blood
|
2011
|
1.50
|
|
6
|
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.
|
J Clin Oncol
|
2008
|
1.25
|
|
7
|
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
|
Br J Haematol
|
2010
|
1.16
|
|
8
|
Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
|
Biol Blood Marrow Transplant
|
2009
|
1.11
|
|
9
|
Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC.
|
Biol Blood Marrow Transplant
|
2011
|
1.03
|
|
10
|
Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation.
|
Cancer
|
2012
|
0.99
|
|
11
|
Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
|
J Clin Virol
|
2006
|
0.98
|
|
12
|
Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study.
|
Exp Hematol
|
2012
|
0.94
|
|
13
|
Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
|
Haematologica
|
2010
|
0.88
|
|
14
|
Management of bilateral masseter muscle hypertrophy.
|
J Craniofac Surg
|
2012
|
0.88
|
|
15
|
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
|
Eur J Haematol
|
2013
|
0.88
|
|
16
|
Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry.
|
Exp Hematol
|
2013
|
0.88
|
|
17
|
Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
|
Haematologica
|
2011
|
0.84
|
|
18
|
Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITD.
|
Biol Blood Marrow Transplant
|
2012
|
0.84
|
|
19
|
Allogeneic hematopoietic stem cell transplantation in ovarian cancer-the EBMT experience.
|
Int J Cancer
|
2010
|
0.83
|
|
20
|
Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas.
|
Haematologica
|
2013
|
0.83
|
|
21
|
Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
|
Haematologica
|
2013
|
0.81
|
|
22
|
Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodies.
|
Transplantation
|
2005
|
0.81
|
|
23
|
Complete or a partial sheet of deep temporal fascial graft as a radix graft for radix augmentation.
|
Eur Arch Otorhinolaryngol
|
2011
|
0.80
|
|
24
|
[Update on soft tissue sarcomas].
|
Bull Cancer
|
2002
|
0.77
|
|
25
|
Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation.
|
Orphanet J Rare Dis
|
2014
|
0.77
|
|
26
|
Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor.
|
Ann Hematol
|
2012
|
0.77
|
|
27
|
Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients.
|
Exp Hematol
|
2013
|
0.77
|
|
28
|
Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC).
|
Eur J Haematol
|
2014
|
0.77
|
|
29
|
Prevalence and risk factors of alcohol and substance abuse among motorcycle drivers in Fars province, Iran.
|
Chin J Traumatol
|
2016
|
0.75
|
|
30
|
Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
31
|
The comparative study of thin and thick surgical splint during Le Fort I osteotomy in vertical maxillary excess.
|
J Craniofac Surg
|
2013
|
0.75
|
|
32
|
Outcomes of arthrocentesis for the treatment of internal derangement pain: with or without corticosteroids?
|
J Craniofac Surg
|
2014
|
0.75
|
|
33
|
Spatial changes of the chin in the vertical and sagittal planes after superior repositioning of the maxilla.
|
J Craniofac Surg
|
2015
|
0.75
|
|
34
|
Comparable outcome after related or unrelated allogeneic stem cell transplant following reduced conditioning with fludarabine, busulfan and antithymocyte globulin.
|
Leuk Lymphoma
|
2011
|
0.75
|
|
35
|
Methotrexate Reduces the Incidence of Severe Acute Graft-versus-Host Disease without Increasing the Risk of Relapse after Reduced-Intensity Allogeneic Stem Cell Transplantation from Unrelated Donors.
|
Biol Blood Marrow Transplant
|
2010
|
0.75
|
|
36
|
Lenalidomide induces remission and mixed quantitative chimerism fluctuations in refractory and relapsed myeloid malignancy with del (5).
|
Leuk Res
|
2010
|
0.75
|
|
37
|
Effect of Low-Level Laser and Light-Emitting Diode on Inferior Alveolar Nerve Recovery After Sagittal Split Osteotomy of the Mandible: A Randomized Clinical Trial Study.
|
J Craniofac Surg
|
2017
|
0.75
|
|
38
|
Effect of chloroquine on some clinical and biochemical parameters in non-response chronic hepatitis C virus infection patients: pilot clinical trial.
|
Acta Biomed
|
2016
|
0.75
|
|
39
|
Periosteal Transposition Flap for Graft Coverage and Ridge Preservation in the Aesthetic Zone.
|
J Craniofac Surg
|
2015
|
0.75
|
|
40
|
High prevalence of hypertension among Iranian children and adolescents: a systematic review and meta-analysis.
|
J Hypertens
|
2017
|
0.75
|